118 related articles for article (PubMed ID: 15231365)
1. Muscarinic subtype-2 receptor autoantibodies: actors or bystanders in human atrial fibrillation?
Dobrev D; Christ T; Ravens U
Eur Heart J; 2004 Jul; 25(13):1091-2. PubMed ID: 15231365
[No Abstract] [Full Text] [Related]
2. Autoantibodies in atrial fibrillation: actors, biomarkers or bystanders? How far have we come?
Fu M
Cardiology; 2009; 112(3):178-9. PubMed ID: 18667820
[No Abstract] [Full Text] [Related]
3. Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy.
Baba A; Yoshikawa T; Fukuda Y; Sugiyama T; Shimada M; Akaishi M; Tsuchimoto K; Ogawa S; Fu M
Eur Heart J; 2004 Jul; 25(13):1108-15. PubMed ID: 15231368
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in atrial fibrillation: actor, biomaker or bystander?
Baba A; Fu M
Autoimmunity; 2008 Sep; 41(6):470-2. PubMed ID: 18781473
[TBL] [Abstract][Full Text] [Related]
5. Effects of autoantibodies against M2 muscarinic acetylcholine receptors on rabbit atria in vivo.
Hong CM; Zheng QS; Liu XT; Shang FJ; Wang HT; Jiang WR
Cardiology; 2009; 112(3):180-7. PubMed ID: 18679026
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against M2-muscarinic and β adrenergic receptors: New mediators in atrial fibrillation?
He B; Lu Z; He W; Jiang H
Int J Cardiol; 2015 Oct; 197():180-1. PubMed ID: 26142203
[No Abstract] [Full Text] [Related]
7. Association of β1-Adrenergic, M2-Muscarinic Receptor Autoantibody with Occurrence and Development of Nonvalvular Atrial Fibrillation.
Hu B; Sun Y; Li S; Sun J; Liu T; Wu Z; Feng LI
Pacing Clin Electrophysiol; 2016 Dec; 39(12):1379-1387. PubMed ID: 27862036
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.
Nussinovitch U; Shoenfeld Y
Clin Rev Allergy Immunol; 2012 Jun; 42(3):298-308. PubMed ID: 21207192
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Ultrastructural Alterations and Declined M2 Receptor Density Were Involved in Cardiac Dysfunction in Rats after Long Term Treatment with Autoantibodies against M2 Muscarinic Receptor.
Zhang S; He Z; Wang J; Wang L; Wu Y; Wang J; Lv T; Liu H
PLoS One; 2015; 10(6):e0129563. PubMed ID: 26086781
[TBL] [Abstract][Full Text] [Related]
10. Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism.
Stavrakis S; Yu X; Patterson E; Huang S; Hamlett SR; Chalmers L; Pappy R; Cunningham MW; Morshed SA; Davies TF; Lazzara R; Kem DC
J Am Coll Cardiol; 2009 Sep; 54(14):1309-16. PubMed ID: 19778674
[TBL] [Abstract][Full Text] [Related]
11. DNA immunizations with M2 muscarinic and beta1 adrenergic receptor coding plasmids impair cardiac function in mice.
Giménez LE; Hernández CC; Mattos EC; Brandão IT; Olivieri B; Campelo RP; Araújo-Jorge T; Silva CL; Campos de Carvalho AC; Kurtenbach E
J Mol Cell Cardiol; 2005 May; 38(5):703-14. PubMed ID: 15850564
[TBL] [Abstract][Full Text] [Related]
12. Elevated M2-muscarinic and β1-adrenergic receptor autoantibody levels are associated with paroxysmal atrial fibrillation.
Yalcin MU; Gurses KM; Kocyigit D; Kesikli SA; Ates AH; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Oto MA; Guc D; Ozer N; Aytemir K
Clin Res Cardiol; 2015 Mar; 104(3):226-33. PubMed ID: 25351416
[TBL] [Abstract][Full Text] [Related]
13. Immunization with plasmids encoding M2 acetylcholine muscarinic receptor epitopes impairs cardiac function in mice and induces autophagy in the myocardium.
Ribeiro KC; Campelo RP; Rodrigues DDRF; Mattos EC; Brandão IT; da Silva CL; Bouskela E; Martinez CG; Kurtenbach E
Autoimmunity; 2018 Aug; 51(5):245-257. PubMed ID: 30424681
[TBL] [Abstract][Full Text] [Related]
14. Anti-M2 muscarinic receptor autoantibodies and idiopathic dilated cardiomyopathy.
Fu ML
Int J Cardiol; 1996 May; 54(2):127-35. PubMed ID: 8803676
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune mechanisms underlying dilated cardiomyopathy.
Yoshikawa T; Baba A; Nagatomo Y
Circ J; 2009 Apr; 73(4):602-7. PubMed ID: 19246813
[TBL] [Abstract][Full Text] [Related]
16. Anti-adrenergic and muscarinic receptor autoantibodies in a canine model of Chagas disease and their modulation by benznidazole.
Daliry A; Caldas IS; de Figueiredo Diniz L; Torres RM; Talvani A; Bahia MT; de Carvalho AC
Int J Cardiol; 2014 Jan; 170(3):e66-7. PubMed ID: 24268984
[No Abstract] [Full Text] [Related]
17. Autoantibodies of β-adrenergic and M2 cholinergic receptors: atrial fibrillation in hyperthyroidism.
Jia G; Sowers JR
Endocrine; 2015 Jun; 49(2):301-3. PubMed ID: 25700563
[No Abstract] [Full Text] [Related]
18. Characterization of anti-heart M2 muscarinic receptor antibodies--a combined clinical and experimental study.
Fu ML
Mol Cell Biochem; 1996; 163-164():343-7. PubMed ID: 8974074
[TBL] [Abstract][Full Text] [Related]
19. Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy.
Baba A
Ther Apher Dial; 2008 Apr; 12(2):109-16. PubMed ID: 18387158
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas' heart disease.
Levin MJ; Hoebeke J
Autoimmunity; 2008 Sep; 41(6):429-33. PubMed ID: 18781468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
